Ann: Annual Report to shareholders, page-4

I’d have to both agree and disagree.

Agreed, there will be no rocket next week or anytime soon. The latest corporate slide deck for Sept 20 regurgitates the same pre-clinical data we have been reading of for literally years. Year after year it has been setbacks and excuses, well setbacks followed by silence actually. There is literally nothing in the short term to turn this life styler around.

However I must disagree the latest inaction, silence, and display of mismanagement has had an overwhelmingly material impact on the share price, down some 60% from the capital raise and over 70% down from the recent high Over two moths of decline and silence.

Nothing new here, rinse and repeat.

Awaiting the next company orchestrated pump and dump.